Last reviewed · How we verify

NCT03090763

Role of Circulating MicroRNAs in Pathogenesis of Aneurysms of the Abdominal and Thoracic Aorta - Study "Micro AAA"

Status unknown Last updated 27 March 2017
What this trial tests

trial testing PCR and sequencing in Aortic Aneurysm in 200 participants. Status unknown.

Timeline
1 November 2016
Primary endpoint
1 May 2018
1 June 2019

Quick facts

Lead sponsorCharles University, Czech Republic
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date1 November 2016
Primary completion1 May 2018
Estimated completion1 June 2019
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Charles University, Czech Republic

Who can join

18 and older, any sex, with Aortic Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to establish whether patients with aortic aneurysm, compared to general population, have higher levels of selected miRNAs and whether there is significant association between the level of miRNA in circulating blood and the size of the aortic aneurysm or the risk of its rupture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm

Currently open trials in the same condition.

Other Charles University, Czech Republic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03090763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing